Inflammasome as a key pathogenic mechanism in endometriosis
P Bullon, J Manuel Navarro - Current Drug Targets, 2017 - ingentaconnect.com
Background: Endometriosis remains a challenging condition for clinicians to treat. To
improve our results, we have to develop new treatment strategies based on …
improve our results, we have to develop new treatment strategies based on …
[PDF][PDF] Inflammasome As a Key Pathogenic Mechanism in Endometriosis
P Bullona, JM Navarrob - Current Drug Targets, 2016 - researchgate.net
Endometriosis remains a challenging condition for clinicians to treat. To improve our results,
we have to develop new treatment strategies based on pathophysiological mechanisms …
we have to develop new treatment strategies based on pathophysiological mechanisms …
[引用][C] Inflammasome as a Key Pathogenic Mechanism in Endometriosis
P Bullon, JM Navarro - Current Drug Targets, 2017 - cir.nii.ac.jp
Inflammasome as a Key Pathogenic Mechanism in Endometriosis | CiNii Research CiNii
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …
Inflammasome as a Key Pathogenic Mechanism in Endometriosis.
P Bullon, JM Navarro - Current Drug Targets, 2017 - europepmc.org
Background Endometriosis remains a challenging condition for clinicians to treat. To
improve our results, we have to develop new treatment strategies based on …
improve our results, we have to develop new treatment strategies based on …
Inflammasome as a Key Pathogenic Mechanism in Endometriosis
P Bullon, JM Navarro - Current drug targets, 2017 - pubmed.ncbi.nlm.nih.gov
Background Endometriosis remains a challenging condition for clinicians to treat. To
improve our results, we have to develop new treatment strategies based on …
improve our results, we have to develop new treatment strategies based on …